Virtuous alliances prove to be of great importance for health. Thus it is worth underlining that the Medical Genetics Operational Unit of the Irccs San Raffaele is the first structure in Italy to adopt a new platform dedicated to Roche research. The instrumentation, based on the innovative DNA expansion sequencing (SBX) technology, is capable of performing complete genome sequencing in just a few hours. There are only a few dozen machines of this type in the world.
What changes
With Sequencing by Expansion (SBX) we go even further than the progress of recent years, which has allowed fundamental steps forward. Currently, in fact, next generation sequencing (Next Generation Sequencing – NGS) has transformed genomic research, expanding knowledge on the genetic and molecular mechanisms underlying numerous complex pathologies with high social impact, and opening new perspectives for precision medicine.
However, the full exploitation of these opportunities requires increasingly accessible, rapid and flexible technologies, capable of responding to the different needs of research laboratories. The new platform was developed to help overcome some of the key challenges of genomic sequencing, including high costs, analysis times and limited flexibility in managing volumes.
Thanks to SBX (sequencing by expansion) technology, the platform combines accuracy, speed, scalability and cost efficiency, allowing laboratories of different sizes to modulate workflows according to their needs and promoting more efficient use of resources. The speed, in particular, allows you to reduce sequencing times from days to hours. Since the presentation of the SBX technology in early 2025, numerous research applications have been tested, including whole genome sequencing, the whole exome or the set of exons, i.e. the regions of DNA that contain the instructions for producing proteins, and single cell RNA sequencing (shows which genes are active in each single cell at a given time, measuring the RNA produced) as well as methylation, which leads to “switching off” or silencing in DNA the expression of a gene without changing the DNA sequence itself. Furthermore, the platform is designed to analyze numerous samples simultaneously and has a flexible and scalable architecture, which adapts to different work volumes.
The prospects for research
The perspectives opened by the evolution of genomics take on particular importance in the IRCCS, where research and clinical activity are closely connected. In this context, the comparison with new technologies allows us to explore their potential contribution to scientific progress and evaluate their prospects for people’s health.
“The future of genomics lies in the ability to transform whole-genome information into a deeper understanding of health and disease”
reports Sabrina Giglio, Director of the Medical Genetics Operational Unit of the Irccs San Raffaele Hospital.
“An innovation in sequencing such as that brought by the new Roche platform can expand the questions that research is able to address and help us better understand complex pathologies. We look to a future in which genetics becomes an increasingly transversal reference to the different medical disciplines and helps to guide the person’s health journey, from prevention to therapy. The horizon is precision medicine capable of recognizing individual differences and translating this knowledge into increasingly personalized approaches”.









